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Basic science studies remain a critically important part of the knowledge discovery 
process in musculoskeletal science. This review highlights several of the key advances in 
orthopaedic basic science over the last year. The review is not intended to be all-
inclusive, rather it represents the opinions of the author, but it is hoped that the 
information will be of interest to the JBJS readership and will provide an easily digestible 
summary of some of the key recent advances in basic science. It should be noted that 
some topics of tremendous basic science interest, most notably orthopaedic infection 
and neoplasia, are not covered in detail in this article because they have been the topic 
of separate focused review articles in this Journal1, 2.  
 
1. Joints and Joint Disease  
1.1. Joint as an organ 
It is now widely accepted that joint is best considered an organ, rather than a simple 
tissue, and that osteoarthritis (OA) represents a spectrum of pathologies affecting 
several of the core structures that make up the joint. Early understanding of OA focused 
on the changes that were grossly evident on joint inspection, including cartilage 
degradation, subchondral bone sclerosis, synovial inflammation and osteophyte 
formation3. More recently, this picture has been expanded to include the contributions 
of local changes in peri-articular muscles, nerves and intra-articular structures such as 
the fat pad. This expanded understanding of the complexity of joint structure-function 
should facilitate the development of more robust and productive in-vitro models for 
studying joint disease and its management. It will also drive the development of more 
effective regenerative strategies that target multiple aspects of organ function, rather 
than focusing on cartilage repair/regeneration alone.  
 
 
1.2. Post-traumatic OA 
The majority of preclinical induced (i.e. non-natural) models of OA involve the creation 
of traumatic instability within the joint. Although this may have limited the translational 
relevance of studies performed with these models, particularly with regard to the 
efficacy of pharmacological or biological therapies, it has facilitated significant recent 
Manuscript (MS Word Format, Maximum 3200 Words)
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advances in our understanding of the effects of trauma on function of the joint organ. 
Little et al. reported on the use of mouse models of post-traumatic osteoarthritis (PTOA) 
and recommended a classification scheme that incorporates three types of lesions, 
based on the extent of the loading that initiates the damage (type I: loading that 
initiates immediate structural damage and instability; type II: moderate loading with no 
immediate instability; type III: minor loading with no immediate instability)4. Mouse 
models exist for all of the injury types, opening up the potential for detailed and 
comparative studies between different degrees of injury and, in particular, for teasing 
apart the effects of acute versus chronic instability.  
 
Martin et al. have recommended the use of sub-classification in their work on the 
development of predictive models for PTOA5. They have identified three broad 
categories of models that can be used to examine the interactions between mechanical 
overloading and cartilage loss. At one end of the spectrum are the explant and organ 
(joint) culture models that allow for very precise measurement of the cellular response 
to controlled joint loading. In the middle are the animal models in which it is possible to 
study the effects of trauma and instability on joint structure/function, and to evaluate 
the safety and efficacy of candidate interventions. At the other end of the spectrum lies 
the use of in-silico modeling in which patient specific models, built using data from the 
other two types of model, can be used to predict the likely response to injury and the 
most appropriate treatment approach.  
 
1.3. Cartilage Repair and Regeneration 
There is a clear distinction between acute osteochondral injuries, most often the result 
of trauma, and chronic damage that is often associated with OA. This difference is likely 
to be of great significance in the context of developing biological strategies for repairing 
or replacing cartilage that has been lost or damaged, since the microenvironment into 
which biologics are injected/implanted may be significantly different in acute versus 
chronic settings. Improved understanding of normal cartilage development and 
homeostasis is critical to the development of optimal regenerative strategies. For 
example, the recognition that articular cartilage and synovium share common 
precursors has fueled interest in synovium itself as a source of cells for transplant into 
 4 
osteochondral defects6.   
 
Jiang et al recently reported on the identification of cartilage stem/progenitor cells 
(CSPCs) that appear to be capable of self-repair7. These stem-like cells have been found 
in adult human, bovine and equine cartilage, suggesting that they represent a 
biologically conserved strategy for joint homeostasis. The proliferation of CSPCs in cell 
culture can be selectively enhanced through careful control of the culture conditions, 
with 2-dimensional, low density culturing appearing to be most favorable. CPSCs were 
found to be capable of forming hyaline cartilage explants in vivo using a mouse model, 
and follow-up studies in 15 human patients with isolated osteochondral lesions 
produced encouraging results8.  
 
Advances in cell therapies for cartilage repair continue to move in parallel with 
developments in biomaterials for delivering and/or retaining the cells at the site of 
implantation. Current therapies, whether involving local stimulation with microfracture 
or direct replacement with cartilage transplant, appear well suited for small, isolated 
defects. The management of larger, less constrained defects remains more challenging 
and is perhaps the area where regenerative medicine has most to offer. Much of the 
emphasis remains on bioengineering of scaffold structures capable of resurfacing large 
areas of the joint has also seen significant advances. In some cases, for example 
meniscus, it may be sufficient to rely on the biomaterial alone for replacement of the 
structure9, but for articular cartilage a seeded construct may represent a better 
approach. Moutos et al. have used a woven, anatomically contoured scaffold to support 
the directed expansion of adipose-derived stem cells, leading to the formation of a 
robust hyaline cartilage that may find clinical utility in resurfacing the femoral head [10].  
 
 
2. Crosstalk Amongst Tissues 
 
2.1. Interactions between bone and muscle  
The effects of direct muscle forces on bone mass and bone structure have been studied 
for many years, but it is increasingly apparent that there are significant muscle-bone 
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interactions that are not based on mechanical effects11. The recognition of both bone 
and muscle as secretory, endocrine organs has changed that we think about muscle-
bone interactions. Starting with myostatin, the list of muscle-derived chemokines, or 
myokines, continues to expand and it has been suggested that these molecules may play 
a pivotal role in the health-related benefits of physical exercise on cardiac, brain, renal 
and hepatic function12. More recent work, much of it based on studies in genetically 
modified mice, has established that both FGF-23 and osteocalcin, produced within bone, 
exert important remote effects. Deletion of FGF23 expression within bone leads to 
disorders of phosphate metabolism13, and deletion of osteocalcin produces disturbances 
in energy metabolism through effects on glucose metabolism14.   
 
2.2. Interactions beyond muscle 
Across medicine there is a growing interest in the role of the central nervous system and 
its associated neuropeptides on the function of other organs. Leptin, first identified as a 
modulator of appetite and satiety, has also been shown to exert influence bone mass 
both remotely, via direct effects on bone cells, as well as centrally in the brain15. The 
sympathetic and parasympathetic components of the autonomic nervous system have 
also come under increasing scrutiny both for their sensory functions as well as for their 
effector functions in linking the brain and the skeleton16. Much remains to be 
determined regarding the specifics of these interactions, but it is clear that the 
dissection of these pathways will be illuminating in terms of both improving our 
understanding of bone disease and in identifying potential targets for therapy. 
 
2.3. Osteoimmunology 
Interactions between bone cells and cells of the immune system have been a topic of 
great interest for several years, with the initial focus being on the role of T cells in 
inflammatory bone and joint conditions. Recognition of the hematopoietic stem cell 
niche, and the role played by bone cells in establishing and maintaining it, served to 
further highlight the significance of bone-immune cell interactions in vivo. Recent work 
has identified the importance of T-cell mediated interactions in defining skeletal 
responsiveness to parathyroid hormone17 and the potential role of activated NK cells in 
controlling osteoclastic activity within inflammatory bone lesions18.  
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2.4. Bone and the microbiome  
In the context of remote regulators of bone turnover, another more recent area of 
research interest is the influence of gut microbiota19. The microbiome has been shown 
to be a key regulator of many homeostatic processes that occur outside the 
gastrointestinal tract, including important effects on the host immunity, and studies in 
mice have shown that the gut microbiota can influence bone mass. This has led to 
interest in the use of probiotics to modulate bone mass20, 21, although much remains to 
be determined in order to identify the optimal combination of probiotic, timing and 
duration of treatment 
 
3. Mechanism(s) of action of adult stem cells   
Stem cells remain one of the most exciting potential vehicles for delivering therapy in 
musculoskeletal disease. Techniques for isolating, expanding and characterising adult 
stem cells from bone marrow, adipose tissue, cord blood, peripheral blood or synovium 
continue to evolve, but the relative scarcity of viable progenitor cells in the source tissue 
remains a significant challenge. Several recent papers have presented potential 
approaches to improve the clinical utility of MSCs at effectors of musculoskeletal tissue 
regeneration.  
 
Sheyn et al. made use of recent advances in somatic cell reprogramming to generate 
inducible pluripotential stem cells (iPSCs) and then differentiated them into MSCs using 
transforming growth factor-beta22. The induced MSCs were found to be pluripotential in 
vitro and were more effective than bone marrow-derived, non-induced MSCs 
transduced with the gene for bone morphogenetic protein-6 in repairing radial defects 
in mice. 
 
The use of synovial derived MSCs has been reported in two recent papers. In the first, 
human cells were infected into the knee joints of rats that had undergone transection of 
the anterior cruciate ligament one week previously23. A single injection of cells was 
found to be ineffective in modulating the progression of degenerative joint disease, but 
repeated weekly injections were found to be chondroprotective over a 12-week period. 
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Using immunohistochemistry, the authors demonstrated that the majority of the 
injected cells remained undifferentiated in vivo, functioning instead as local sources for 
chondroprotective proteins and anti-inflammatory cytokines.  
 
The second paper explored the use of autologous synovial-derived MSCs in the 
regeneration of meniscal defects in a non-human primate model24. MSC aggregates 
were implanted directly into defects in the anterior half of the medial meniscus, and the 
animals were followed for either 8 or 16 weeks. The reparative response in the 
meniscus, and any attendant changes in the adjacent articular cartilage, were assessed 
by MRI, gross observation and histopathology. In this model, MSCs promoted meniscal 
regeneration and delayed progression of cartilage damage and OA.  
 
4. The role of Clock genes and diurnal variations in gene expression. 
The importance of diurnal variation has been established in many areas of 
musculoskeletal biology, including bone turnover. Earlier work showed that loss of clock 
genes eliminates the ability of bone to respond to leptin25 but more recently attention 
has moved to looking at the clock genes in the context of articular cartilage.  Dudek at al. 
reported that targeted disruption of the clock transcription factor, BMAL1, abolished 
normal circadian expression of a number of genes associated with cartilage 
homeostasis26. BLAL1 expression is also reduced in cartilage explants from humans with 
OA and from aged mice, implicating BLAL1 as an important potential factor in OA 
progression. Guo et al. have gone on to find that the regulation of clock-controlled 
genes is itself disrupted by catabolic cytokines implicated in cartilage degradation27. In 
the context of spinal disease, an interesting study in rats demonstrated that passive 
exposure to cigarette smoke resulted in a significant (6- to 9-hour) frame shift in the 
activity of clock genes in the intervertebral disc28.  
 
5. Gene editing with CRISPR-Cas9 
Selective gene targeting using clustered regularly interspersed short palindromic repeat 
(CRISPR) technology and the RNA-guided nuclease, Cas9, has rapidly become the 
predominant gene-editing tool in genomics. In the last year there have been a number 
of high profile and very exciting publications that report on the use of CRISPR-Cas9 gene 
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editing in the study of musculoskeletal disorders. In Duchenne muscular dystrophy, a 
series of three complimentary papers reported on the successful use of this technology 
to restore dystrophin expression in a mouse model of the disease29-31. There has also 
been some very nice recent work on the use of this technology to target musculoskeletal 
cancers such as osteosarcoma32. 
 
6. Metabolomics and the identification of disease signatures and therapeutic targets  
The use of wide-scale screening of tissue samples using proteomics has produced 
interesting observations across a range of orthopaedic conditions. Mickiewicz et al. have 
reported on the use of metabolomics to identify a potential signature for 
osteoarthritis33. Liu et al. compared metabolomics profiles in plasma samples from 30 
clinical patients with osteonecrosis of the femoral head with those from 30 control 
patients, finding that 123 metabolites were differentially expressed in the two 
populations34. Interestingly, many of these candidate markers were involved in lipid-, 
glutathione- and energy-associated pathways that might be associated with 
inflammation, oxidative stress and energy deficiencies that have been implicated in the 
pathogenesis of osteonecrosis. In a mouse model, Shum et al. used metabolomics to 
demonstrate that mitochondrial oxidative function is impaired in aged animals and that 
the negative effects of aging on bone formation, bone mass and bone strength can be 
partially reversed by targeting cyclophilin D, a key determinant of mitochondrial 
function35.   
 
7. Animal models and their reproducibility  
The last decade has seen a significant increase in public awareness regarding the 
contentious issue of animal use in biomedical research. One of the fundamental tenets 
animal research is that the “benefit” (to patients and society at large) should exceed the 
“cost” to the animal in terms of pain and distress. As a result of improvements in the 
level of detail at which researchers and clinicians are now able to characterise disease 
processes, it is becoming evident that many of the induced disease models that are used 
routinely fail to completely replicate the pathology that is seen in the clinic. Even more 
disturbing is the suggestion that even when validated animal models are used, variability 
in how animal models are used means that it is often impossible to make direct 
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comparisons between studies performed at different institutions or by different 
investigators. The National Institutes of Health has identified irreproducibility as a major 
obstacle to scientific advances36 and, according to a recent publication, this problem of 
irreproducibility cost approximately $28 billion37.  
 
Arguments are being made that the 3Rs should now be expanded to the 4Rs or even the 
5Rs to incorporate the need for reproducibility and (clinical) relevance as a model. In 
the meantime, the orthopaedic research community is encouraged to work collectively 
to identify and propagate best practices in the use of animal models in its work38. 
Journals will continue to play a pivotal role in ensuring the integrity of this process by 
requiring that authors (a) verify that the work has been approved by the relevant 
national regulatory authority, and (b) provide enough specific detail in the Methods 
section to ensure that the work can be replicated by other laboratories.  
 
 
Upcoming Meetings and Events Related to Orthopaedic Basic Science 
The 2017 meeting of the Orthopaedic Research Society annual meeting will be held 
March 19-22, 2017 in San Diego, CA. 
Gordon Research Conference, “Understanding Biology to Achieve Better Cartilage 
Health”, will be held April 2-7, 2017 in Barga, Italy. 
The Bone Research Society will meet 25-27 June, 2017 in Bristol, UK. 
The 2017 meeting of the European Society for Biomechanics will be held 2-5 July, 2017 
in Seville, Spain. 
The 2017 meeting of the American Society for Bone and Mineral Research will be held 
September 9 - 12, 2017 in Denver, CO. 
The 24th annual meeting of the European Orthopaedic Research Society will be held 13-
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☐ Pain management  
☐ Pediatrics  
☐ Rehabilitation  
☐ Shoulder 
☐ Spine 
☐ Sports  
☐ Trauma 
☐ General interest/Does not fit 
any other category 
 
II. Intended Audience: Check as many categories as seem appropriate. Minimum of 1 question 
in each category 
 
☐ Other health 
care personnel 











III. Does this question have an image or images? 
☐ Yes                                     No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
 
Question:  (A patient-care scenario is preferred; see Guidelines) 
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IV. Options: ( in alphabetical or logical order) 
 
A. A popular method for selectively editing genes in cells and tissues  
 
B.  A key molecule in the apoptosis pathway 
C. A monoclonal antibody for treating osteoarthritis 
D. A cell surface receptor implicated in bone remodeling 
E.  A new small molecule inhibitor of osteosarcoma 
 
V. Answer: (must be clearly the best of the options) 
A.  ☐ B.  ☐ C.  ☐ D.  ☐ E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 




VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 




Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
the primary case manager when care involves multiple specialties, 
professions or sites). 
Section on CASPR-Cas9 gene editing 
CME Questions Submission Form (Rev. 04/16) | 5  
 
 
Question 3      (staff use only – question type_____) 
 
I. Question Category:  Check as many categories as seem appropriate. Question category may 
differ from manuscript category. 
 
Basic science 
☐ Ethics  
☐ Elbow 
☐ Foot and ankle 
☐ Hand and wrist 
☐ Hip reconstruction, 
adult 
☐ Infection 
☐ Knee reconstruction, adult 
☐ Oncology 
☐ Pain management  
☐ Pediatrics  
☐ Rehabilitation  
☐ Shoulder 
☐ Spine 
☐ Sports  
☐ Trauma 
☐ General interest/Does not fit 
any other category 
 
II. Intended Audience: Check as many categories as seem appropriate. Minimum of 1 question 
in each category 
 
Other health care 
personnel (e.g., NP, 











III. Does this question have an image or images? 
☐ Yes                                     No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
 
 
IV. Question:  (A patient-care scenario is preferred; see Guidelines) 
 
 
A 34-year old man presents with a history of acute trauma to the knee joint. Radiographs are 
unremarkable but an MRI scan reveals a small (<<0.5 cm2) defect in the cartilage of the tibial 
plateau. The patient is keen to use regenerative therapy for this lesion and asks your advice. 
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V. Options: ( in alphabetical or logical order) 
 
A. A single injection of autologous stem cells into the joint to repopulate the lesion 
and repair the cartilage 
B.  Surgical debridement and replacement of the resulting defect with a woven 
synthetic scaffold  
C. Surgical debridement and replacement of the resulting defect with a woven 
synthetic scaffold seeded with stem cells 
D. No treatment – the lesion will heal on its own 
E.  Standard surgical debridement followed by microfracture 
 
VI. Answer: (must be clearly the best of the options) 
☐ A.  ☐ B.  ☐ C.  ☐ D.  E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 




VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
 Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 




Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
Section of cartilage repair  
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the primary case manager when care involves multiple specialties, 
professions or sites). 
 
Question 4      (staff use only – question type_____)  
 
I. Question Category:  Check as many categories as seem appropriate. Question category may 
differ from manuscript category. 
 
Basic science 
☐ Ethics  
☐ Elbow 
☐ Foot and ankle 
☐ Hand and wrist 
☐ Hip reconstruction, 
adult 
☐ Infection 
☐ Knee reconstruction, adult 
☐ Oncology 
☐ Pain management  
☐ Pediatrics  
☐ Rehabilitation  
☐ Shoulder 
☐ Spine 
☐ Sports  
☐ Trauma 
☐ General interest/Does not fit 
any other category 
 
II. Intended Audience: Check as many categories as seem appropriate. Minimum of 1 question 
in each category 
 
☐ Other health 
care personnel (e.g. 











III. Does this question have an image or images? 
☐ Yes                                     No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
 
IV. Question:  (A patient-care scenario is preferred; see Guidelines) 
 
 
Improvements are needed in the reproducibility of the animal models that are used in research. 
For a surgical model in rats, which of the following approaches is likely to have the greatest 
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V. Options: ( in alphabetical or logical order) 
 
A. Using animal models that have been published previously  
B.  Using animal models that have been validated by multiple laboratories and that 
have been published previously 
C. Collecting samples at more time points for each animal 
D. Collecting more samples at each time point for each animal 
E.  Using fewer animals for each experimental group 
 
VI. Answer: (must be clearly the best of the options) 
☐ A.  B.  ☐ C.  ☐ D.  ☐ E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 




VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 




Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
Section on animal models and reproducibility 
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the primary case manager when care involves multiple specialties, 
professions or sites). 
 
 
Question 5      (staff use only – question type_____) 
 
I. Question Category:  Check as many categories as seem appropriate. Question category may 
differ from manuscript category. 
 
Basic science 
☐ Ethics  
☐ Elbow 
☐ Foot and ankle 
☐ Hand and wrist 
☐ Hip reconstruction, 
adult 
☐ Infection 
☐ Knee reconstruction, adult 
☐ Oncology 
☐ Pain management  
☐ Pediatrics  
☐ Rehabilitation  
☐ Shoulder 
☐ Spine 
☐ Sports  
☐ Trauma 
☐ General interest/Does not fit 
any other category 
 
II. Intended Audience: Check as many categories as seem appropriate. Minimum of 1 question 
in each category 
 
☐ Other health 
care personnel 










III. Does this question have an image or images? 
☐ Yes                                     No  
(If YES – upload image(s) separately using the ”CME Question Figure” item option in the Attach Files 
screen of Editorial Manager. Include a one to two sentence description of each figure here. All figures 
should be at least 5x7 inches with a resolution of 300 ppi.) 
 
IV. Question:  (A patient-care scenario is preferred; see Guidelines) 
 
There is often a disconnect between the results seen with a new drug therapy in preclinical 
animal models of osteoarthritis and those seen in the later clinical trials. It has been suggested 











V. Options: ( in alphabetical or logical order) 
 
A. Mice and rats have different gastrointestinal tracts to humans, making it hard for 
them to metabolise oral drug formulations 
B.  Mice and rats are much smaller than humans, making it impossible to accurately 
predict drug dosages 
C. Rats and mice are much smaller than humans, so their joints do not experience 
the same loading 
D. Most of the animal models used to study OA involve the creation of traumatic 
instability within the joint, something that is not a feature of uncomplicated 
primary OA in humans 
E.  Animals are more resilient and do not feel pain in the same way as human 
patients 
 
VI. Answer: (must be clearly the best of the options) 
☐ A.  ☐ B.  ☐ C.  D.  ☐ E. 
 
VII. Answer Location: Please list the heading of the manuscript section where the correct answer 




VIII. Core Competencies addressed by this CME question: 
 ☐ Patient Care: Provide care that is compassionate, appropriate, and effective 
treatment for health problems and to promote health. 
Medical  
     Knowledge:   
Demonstrate knowledge about established and evolving biomedical, 
clinical, and cognate sciences and their application in patient care. 
☐ Practice Based 
Learning and 
Improvement: 
Show and ability to Investigate and evaluate patient care practices, 
appraise and assimilate scientific evidence, and improve the practice 
of medicine. 
☐ Interpersonal and 
    Communication  
    Skills:  
Demonstrate skills that result in effective information exchanges and 
teaming with patients, their families and professional associates (e.g. 
fostering a therapeutic relationship that is ethically sound, used 
effective listening skills with non-verbal and verbal communication; 
working as both a team member and at times a leader). 
Section on “Post-traumatic OA” 
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☐ Professionalism:  Demonstrate a commitment to carrying out professional 
responsibilities, adherence to ethical principles, and sensitivity to a 
diverse patient population. 
☐ Systems-Based 
     Practice: 
Demonstrate awareness of and responsiveness to the larger context 
and systems of health care. Be able to call on system resources to 
provide optical care (e.g. coordinating care across sites or serving as 
the primary case manager when care involves multiple specialties, 
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